KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) EBT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.07%
Dec 31, 2025 16.44%
Sep 30, 2025 6.65%
Jun 30, 2025 1.73%
Mar 31, 2025 63.75%
Dec 31, 2024 27.40%
Sep 30, 2024 4.44%
Jun 30, 2024 -6.25%
Mar 31, 2024 -50.88%
Dec 31, 2023 2.15%
Sep 30, 2023 -0.28%
Jun 30, 2023 29.17%
Mar 31, 2023 9.26%
Dec 31, 2022 21.64%
Sep 30, 2022 13.30%
Jun 30, 2022 8.62%
Mar 31, 2022 -2.91%
Dec 31, 2021 11.34%
Sep 30, 2021 6.71%
Jun 30, 2021 -0.78%
Mar 31, 2021 8.86%
Dec 31, 2020 -91.11%
Sep 30, 2020 17.99%
Jun 30, 2020 99.10%
Mar 31, 2020 -17.19%
Dec 31, 2019 -16.54%
Sep 30, 2019 6.00%
Jun 30, 2019 31.71%
Mar 31, 2019 14.97%
Dec 31, 2018 11.61%
Sep 30, 2018 21.51%
Jun 30, 2018 -0.50%
Mar 31, 2018 21.42%
Dec 31, 2017 6.35%
Sep 30, 2017 24.07%
Jun 30, 2017 4.11%
Mar 31, 2017 -0.72%
Dec 31, 2016 -7.39%
Sep 30, 2016 -3.15%
Jun 30, 2016 -2.04%
Mar 31, 2016 -1.30%
Dec 31, 2015 13.05%
Sep 30, 2015 -9.37%
Jun 30, 2015 -49.56%
Mar 31, 2015 -0.06%
Dec 31, 2014 -15.39%
Sep 30, 2014 -8.42%
Jun 30, 2014 -21.70%
Mar 31, 2014 -3.79%